Geneos Therapeutics

Hubro Therapeutics

This company develops neoantigen-targeted cancer vaccines for patients with gastrointestinal cancers to activate anti-cancer specific T-cell immune responses.

Revealis Biotherapeutics

This company develops therapeutic cancer vaccines targeting immune-escaped and immunotherapy-resistant tumours for healthcare providers and patients.

Genevation

This biotechnology company develops personalised mRNA cancer vaccines and therapeutics using artificial intelligence for patients requiring precision oncology treatments.

Bactheravax

This company develops therapeutic vaccines targeting tumour-associated bacteria to improve treatment sensitivity and immune responses for patients with colorectal and other cancers.

TILT Biotherapeutics

This company develops oncolytic viral immunotherapies to treat patients with solid tumours by enhancing immune system responses against cancer cells.

Neogene Therapeutics

This biotechnology company develops engineered T cell receptor therapies targeting neoantigens in solid cancers for patients with oncology needs.

Medici Therapeutics

The company develops personalised mRNA cancer vaccines and T cell therapies for patients to treat tumours and combat age-related cellular decline.

Haptena Therapeutics

This biotechnology company develops immunotherapies for patients with oncogene-driven cancers by integrating precision oncology with immune engineering.